Multi‐OMICs orchestration enabled by artificial intelligence in inflammatory bowel disease: An exciting future
2024

AI and Multi-OMICs in Inflammatory Bowel Disease

Editorial

Author Information

Author(s): Marietta Iacucci, Giovanni Santacroce

Primary Institution: APC Microbiome Ireland, College of Medicine and Health, University College Cork

Conclusion

AI can significantly enhance the integration of multi-OMICs data in inflammatory bowel disease, leading to better personalized patient care.

Supporting Evidence

  • AI can standardize and integrate multi-OMICs data for better insights.
  • The integration of diverse patient data can improve treatment decisions.
  • AI has the potential to enhance personalized medicine in inflammatory bowel disease.

Takeaway

This study talks about how using artificial intelligence can help doctors understand and treat inflammatory bowel disease better by looking at lots of different patient data together.

Limitations

The study highlights challenges such as data quality, reproducibility, and the need for specialized expertise in data analysis.

Digital Object Identifier (DOI)

10.1002/ueg2.12663

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication